813P Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): A multicenter, phase II clinical trial
暂无分享,去创建一个
K. Yonemori | K. Ariyoshi | K. Hasegawa | K. Takehara | A. Hirakawa | Koji Matsumoto | Kenichi Nakamura | A. Hamada | T. Kato | H. Yoshida | Y. Hirashima | S. Yagishita | T. Nishikawa | M. Kawasaki | M. Mori | Y. Nagasaka | S. Tomatsuri